Literature DB >> 10965091

Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction.

T Kanda1, M Inoue, N Kotajima, S Fujimaki, Y Hoshino, M Kurabayashi, I Kobayashi, J Tamura.   

Abstract

Interleukin-6 (IL-6), a proinflammatory cytokine, plays a key role in the pathogenesis of coronary artery disease (CAD). We investigated circulating IL-6 and its receptors in patients with CAD. We evaluated 39 Japanese patients with CAD (30 males and 9 females aged 36-79 years), measuring their plasma levels of IL-6 and IL-6 receptors alpha and beta (IL-6R alpha, IL-6R beta). Circulating levels of IL-6, IL-6R alpha and IL-6R beta were measured by an enzyme-linked immunosorbent assay. Blood was sampled immediately after admission and again after 1, 2, 3, 6 and 9 h, then every 12 h for 5 days. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were measured on day 3 after symptom onset. Plasma levels of IL-6 and IL-6Rs were significantly increased in 28 patients with acute myocardial infarction (AMI) compared with 15 normal controls. However, neither IL-6 nor IL-6Rs showed an increase in 6 patients with angina pectoris. We observed two peaks for circulating IL-6 in AMI, the first of which showed a significant correlation with ANP as well as BNP. These results may help to explain why the amount of IL-6 produced is closely related to the severity of myocardial dysfunction in patients with CAD. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965091     DOI: 10.1159/000007025

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  14 in total

1.  Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

Authors:  J E Sanderson; K B Lai; I O Shum; S Wei; L T Chow
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

Authors:  G Hetet; B Grandchamp; C Bouchier; V Nicaud; L Tiret; G Roizès; M Desnos; K Schwartz; R Dorent; M Komajda
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Contrast enhanced magnetic resonance angiography and pulmonary venous anomalies.

Authors:  F Godart; S Willoteaux; C Rey; B Cocheteux; C Francart; J P Beregi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.

Authors:  D Birnie; L P Soucie; S Smith; A S Tang
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

5.  Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction.

Authors:  N Kotajima; T Kimura; T Kanda; A Kuwabara; Y Fukumura; M Murakami; I Kobayashi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

6.  Percutaneous aortic valve replacement: will we get there?

Authors:  Y Boudjemline; P Bonhoeffer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Tetrahydrobiopterin attenuates cholesterol induced coronary hyperreactivity to endothelin.

Authors:  S Verma; A S Dumont; A Maitland
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

8.  A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.

Authors:  S Rafiq; T M Frayling; A Murray; A Hurst; K Stevens; M N Weedon; W Henley; L Ferrucci; S Bandinelli; A-M Corsi; J M Guralnik; D Melzer
Journal:  Genes Immun       Date:  2007-08-02       Impact factor: 2.676

9.  alpha1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB.

Authors:  Dianne M Perez; Robert S Papay; Ting Shi
Journal:  Mol Pharmacol       Date:  2009-04-10       Impact factor: 4.436

10.  Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.

Authors:  A Arakelyan; J Petrkova; Z Hermanova; A Boyajyan; J Lukl; M Petrek
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.